A Registry Study of Biomarkers in Heart Valve Disease (BIOMS-HVD)

B

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status

Enrolling

Conditions

Cardiovascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT06223906
BIOMS-HVD

Details and patient eligibility

About

Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches

Enrollment

200,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital

Exclusion criteria

  • Age < 18 years
  • Failure to obtain medical records and ultrasound data
  • Refuse follow-up

Trial contacts and locations

1

Loading...

Central trial contact

Yuan Wang, Dr; Rui Lin, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems